Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV002575989 | SCV002938657 | uncertain significance | Early-onset Parkinson disease 20; Developmental and epileptic encephalopathy, 53 | 2022-02-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with SYNJ1-related conditions. This variant is present in population databases (rs774571965, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 1194 of the SYNJ1 protein (p.Arg1194Gly). |
| Ambry Genetics | RCV003164769 | SCV003897358 | uncertain significance | Inborn genetic diseases | 2023-02-15 | criteria provided, single submitter | clinical testing | The c.3580A>G (p.R1194G) alteration is located in exon 27 (coding exon 27) of the SYNJ1 gene. This alteration results from a A to G substitution at nucleotide position 3580, causing the arginine (R) at amino acid position 1194 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |